The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Issue 11 (28th August 2018)
- Record Type:
- Journal Article
- Title:
- The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Issue 11 (28th August 2018)
- Main Title:
- The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
- Authors:
- Mullish, Benjamin H
Quraishi, Mohammed Nabil
Segal, Jonathan P
McCune, Victoria L
Baxter, Melissa
Marsden, Gemma L
Moore, David J
Colville, Alaric
Bhala, Neeraj
Iqbal, Tariq H
Settle, Christopher
Kontkowski, Graziella
Hart, Ailsa L
Hawkey, Peter M
Goldenberg, Simon D
Williams, Horace R T - Abstract:
- Abstract : Interest in the therapeutic potential of faecal microbiota transplant (FMT) has been increasing globally in recent years, particularly as a result of randomised studies in which it has been used as an intervention. The main focus of these studies has been the treatment of recurrent or refractory Clostridium difficile infection (CDI), but there is also an emerging evidence base regarding potential applications in non-CDI settings. The key clinical stakeholders for the provision and governance of FMT services in the UK have tended to be in two major specialty areas: gastroenterology and microbiology/infectious diseases. While the National Institute for Health and Care Excellence (NICE) guidance (2014) for use of FMT for recurrent or refractory CDI has become accepted in the UK, clear evidence-based UK guidelines for FMT have been lacking. This resulted in discussions between the British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS), and a joint BSG/HIS FMT working group was established. This guideline document is the culmination of that joint dialogue.
- Is Part Of:
- Gut. Volume 67:Issue 11(2018)
- Journal:
- Gut
- Issue:
- Volume 67:Issue 11(2018)
- Issue Display:
- Volume 67, Issue 11 (2018)
- Year:
- 2018
- Volume:
- 67
- Issue:
- 11
- Issue Sort Value:
- 2018-0067-0011-0000
- Page Start:
- 1920
- Page End:
- 1941
- Publication Date:
- 2018-08-28
- Subjects:
- enteric bacterial microflora -- intestinal microbiology -- colonic microflora -- infective colitis -- inflammatory bowel disease
Gastroenterology -- Periodicals
616.33 - Journal URLs:
- http://gut.bmjjournals.com ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/gutjnl-2018-316818 ↗
- Languages:
- English
- ISSNs:
- 0017-5749
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18284.xml